Alendronate Sodium API
A remarkably potent bisphosphonate compound engineering profound osteoclast inhibition primarily for the aggressive clinical management of osteoporosis and complex bone disease parameters.
CAS Number
121268-17-5
Formula
C₄H₁₂NNaO₇P₂·3H₂O
Mol. Weight
325.12 g/mol
Grade
USP / EP / BP
Product Overview
Alendronate Sodium operates explicitly as a highly resilient bisphosphonate formulation heavily leveraged across the global stage for the mitigation and absolute prevention of deeply rooted osteoporosis metrics. By violently inhibiting osteoclast-mediated bone resorption, it forces a sharp recovery trajectory in bone mineral density massively dropping large-scale fracture vulnerabilities completely.
As a pinnacle distribution mechanism, Jay Overseas explicitly sources Alendronate Sodium through an elite network of extensively audited WHO-GMP compliant endpoints. Every single isolated batch is meticulously fortified with impenetrable global traceability matrixing, fully comprehensive Certificates of Analysis (COA), and heavily integrated USFDA/CEP documentation ensuring immediate commercial greenlights worldwide.
Density Reclamation
Targets biological markers forcing localized density parameters upward aggressively.
Compliance Architecture
Provides a massive, audit-proof paper trail spanning European and North American regulators.
API Snapshot
Bisphosphonate Mechanics
Resorption Acceleration
Severe density loss occurs universally when rapid osteoclast execution actively completely outpaces localized osteoblast bone generation timelines.
Bisphosphonate Binding
Alendronate highly specifically locates and firmly bonds to hydroxyapatite structures buried directly within hostile bone resorption sectors securely.
Osteoclast Collapse
It triggers a direct suppression event paralyzing the osteoclast cascade, effectively forcing bone synthesis to radically overtake dangerous degradation rates.
Therapeutic Applications
Postmenopausal Treatment
Highly targeted prevention and active aggressive treatment structuring directly aimed at postmenopausal osteoporosis.
High-Risk Prophylaxis
Vital preemptive clinical prevention utilized primarily within explicitly diagnosed high-risk osteoporosis patient systems.
Glucocorticoid Shielding
Crucial formulation structuring protecting against severe glucocorticoid-induced localized bone density loss.
Paget's Disease Management
Serves decisively as an aggressive active vector to mitigate heavily accelerated bone remodeling inside Paget's disease.
Quality & Specification Exuberance
Functions explicitly alongside unparalleled synthesis controls delivering heavily guarded, brilliant white crystalline metrics vastly superior to generic production protocols.
Functions flawlessly as a primary bisphosphonate compound immediately inhibiting dangerous osteoclast-mediated bone resorption natively
Dramatically increases absolute bone mineral density driving down compounding systemic fracture incidence rates radically
Operates natively under a completely white crystalline morphology ensuring profoundly stable oral tableting mechanics universally
Offers deep traceability and immense batch-to-batch consistency supported wholly by a flawlessly audited WHO-GMP supply line
Technical Specifications Matrix
Global DMF ✔ Execution Limits
| Sr. | Diagnostic Parameter | Regulatory Specification Limit |
|---|---|---|
| 1 | Description | A white or almost white crystalline powder |
| 2 | Solubility | Soluble in water; practically insoluble in methanol and methylene chloride |
| 3 | Identification: IR Spectrophotometry | Concordant with Sodium Alendronate RS/WS |
| 4 | Identification: Loss on drying | Between 16.1% to 17.1% |
| 5 | Identification: Sodium Salt | Positive reaction |
| 6 | pH Value | 4.0 – 5.0 |
| 7 | Related Impurities (HPLC) | Impurity A: NMT 0.15% | Unspecified: NMT 0.10% | Total: NMT 0.5% |
| 8 | Impurity B and Impurity C | Not more than 0.5% (each) |
| 9 | Loss on drying (140°C to 145°C) | 16.1% to 17.1% (NMT 0.5%) |
| 10 | Assay (By HPLC, Dried Basis) | 98.0% – 102.0% |
Why Sourcing with Jay Overseas Is Invaluable
We actively maintain profound regulatory compliance to bypass complex clearance friction worldwide.
Global Supply Resilience
A fiercely reliable supply chain serving over 50 countries natively, ensuring exact, consistent quality parameters and profoundly timely commercial delivery execution.
Rigorous Regulatory Approvals
Deeply supported by active USFDA DMF filings and formal EU CEP certifications, rigorously compliant with the latest USP, EP, and BP monographs flawlessly.
Uncompromising Impurity Profiling
Guarantees ultra-consistent pure metrics (≥98.0%) alongside a comprehensively mitigated and heavily controlled internal impurity profile, backed by a validated COA.
Export Grade Containment
Routinely deployed securely utilizing specialized internal LDPE barriers completely shielded within highly dense export-worthy external shipping matrices flawlessly.
Ambient Control Parameters
Keep dynamically stored completely at safe room temperature scales ensuring absolutely total blockage of aggressive external moisture penetrations.
Validated Stability Profiling
Maintains intense, fully confirmed systemic chemical integrity over immensely sweeping commercial intervals verified tightly by long-term stability dossier arrays.
Initiate API Formulations Logistics
Secure priority access to comprehensive EU CEP / USFDA DMF documentation chains, extract dedicated volume quotations, and lock in swift international deliveries flawlessly.
Legal Disclaimer: Alendronate Sodium firmly functions as a dedicated institutional active ingredient. Legally transacted expressly exclusively to profoundly certified, globally licensed pharmaceutical synthesis nodes strictly. Independent consumer availability remains totally locked out indefinitely under global mandates.